Apoptosis and cancer: Strategies for integrating programmed cell death

Seminars in Hematology

Volumn 37, Issue 4 SUPPL. 7, 2000, Pages 9-16

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CYTOCHROME C OXIDASE; CYTOKINE; PROTEIN BCL 2; PROTEIN BCL X; RITUXIMAB; TUMOR NECROSIS FACTOR;

APOPTOSIS; CANCER GROWTH; CELL DEATH; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; ENZYME ACTIVITY; FOLLICULAR LYMPHOMA; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033785313     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90055-6     Document Type: Conference Paper

References (42)

1. The Bcl-2 protein family: Arbiters of cell survival
2. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
3. Apoptosis: Mechanisms and roles in pathology
4. Death receptors: Signaling and modulation
5. Proteases to die for
6. IAP family proteins suppressors of apoptosis
7. The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18) (q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
8. Apoptosis: A product of programmed and unprogrammed cell death
9. Controlling cell death
10. Mitochondria and apoptosis
11. BCL-2 family members and the mitochondria in apoptosis
12. How TRAIL kills cancer cells, but not normal cells
13. Toso, a cell surface-specific regulator of Fas-induced apoptosis in T cells
14. Bcl-2-family proteins - The role of the BH 3 domain in apoptosis
15. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
16. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate anti-apoptosis proteins in B-cell chronic lymphocytic leukemia
17. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia
18. Mitochondrial control of cell death
19. Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c
20. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade
21. Bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation
22. Tumor suppressor p53 is a direct transcriptional activator of human Bax gene
23. Checkpoints of dueling dimers foil death wishes
24. Proteolytic activation of the cell death protease Yama/CPP 32 by granzyme B
25. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
26. Bcl-2 and the regulation of programmed cell death
27. Cytochrome c: Can't live with it - Can't live without it
28. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
29. Dysregulation of apoptosis in cancer
30. Caspase activation: The induced-proximity model
31. Caspases: Intracellular signaling by proteolysis
32. Apoptosis in the pathogenesis and treatment of disease
33. Caspases: Enemies within
34. Inhibition of Fas death signals by Flips
35. Apoptosis: Silencing the death receptors
36. Involvement of the Bcl-2 gene in human follicular lymphoma
37. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
38. Placing death under control
39. Tumor necrosis factor receptor and Fas signaling mechanisms
40. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
41. Cell death, the significance of apoptosis
42. Bax suppresses tumorigenesis and stimulates apoptosis in vivo